Cheifetz A - Search Results

1

Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials.

Jones JL, Kaplan GG, Peyrin-Biroulet L, Baidoo L, Devlin S, Melmed GY, Tanyingoh D, Raffals L, Irving P, Kozuch P, Sparrow M, Velayos F, Bressler B, Cheifetz A, Colombel JF, Siegel CA. Jones JL, et al. Among authors: cheifetz a. Clin Gastroenterol Hepatol. 2015 Dec;13(13):2233-40.e1-2; quiz e177-8. doi: 10.1016/j.cgh.2015.06.034. Epub 2015 Jun 30. Clin Gastroenterol Hepatol. 2015. PMID: 26142167 Review.

2

The incidence and management of infusion reactions to infliximab: a large center experience.

Cheifetz A, Smedley M, Martin S, Reiter M, Leone G, Mayer L, Plevy S. Cheifetz A, et al. Am J Gastroenterol. 2003 Jun;98(6):1315-24. doi: 10.1111/j.1572-0241.2003.07457.x. Am J Gastroenterol. 2003. PMID: 12818276

3

The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease.

Cheifetz AS, Kornbluth AA, Legnani P, Schmelkin I, Brown A, Lichtiger S, Lewis BS. Cheifetz AS, et al. Am J Gastroenterol. 2006 Oct;101(10):2218-22. doi: 10.1111/j.1572-0241.2006.00761.x. Epub 2006 Jul 18. Am J Gastroenterol. 2006. PMID: 16848804

4

Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date.

Thukral C, Cheifetz A, Peppercorn MA. Thukral C, et al. Among authors: cheifetz a. Drugs. 2006;66(16):2059-65. doi: 10.2165/00003495-200666160-00002. Drugs. 2006. PMID: 17112300 Review.

5

Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab.

Moss AC, Treister NS, Marsee DK, Cheifetz AS. Moss AC, et al. Among authors: cheifetz as. Gastroenterology. 2007 Feb;132(2):488, 829. doi: 10.1053/j.gastro.2007.01.014. Gastroenterology. 2007. PMID: 17261307 No abstract available.

6

Meta-analysis of the placebo response in ulcerative colitis.

Garud S, Brown A, Cheifetz A, Levitan EB, Kelly CP. Garud S, et al. Among authors: cheifetz a. Dig Dis Sci. 2008 Apr;53(4):875-91. doi: 10.1007/s10620-007-9954-6. Epub 2007 Oct 13. Dig Dis Sci. 2008. PMID: 17934839

7

The utility of capsule endoscopy in patients with suspected Crohn's disease.

Tukey M, Pleskow D, Legnani P, Cheifetz AS, Moss AC. Tukey M, et al. Am J Gastroenterol. 2009 Nov;104(11):2734-9. doi: 10.1038/ajg.2009.404. Epub 2009 Jul 7. Am J Gastroenterol. 2009. PMID: 19584828

8

Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease.

Doherty GA, Bennett GC, Cheifetz AS, Moss AC. Doherty GA, et al. Among authors: cheifetz as. Aliment Pharmacol Ther. 2010 Apr;31(8):802-9. doi: 10.1111/j.1365-2036.2010.04231.x. Epub 2010 Jan 4. Aliment Pharmacol Ther. 2010. PMID: 20055785

9

The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.

Melmed GY, Spiegel BM, Bressler B, Cheifetz AS, Devlin SM, Harrell LE, Irving PM, Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, Siegel CA. Melmed GY, et al. Among authors: cheifetz as. Clin Gastroenterol Hepatol. 2010 Aug;8(8):655-9. doi: 10.1016/j.cgh.2010.04.023. Epub 2010 May 6. Clin Gastroenterol Hepatol. 2010. PMID: 20451665

10

Cyclosporine is safe and effective in patients with severe ulcerative colitis.

Cheifetz AS, Stern J, Garud S, Goldstein E, Malter L, Moss AC, Present DH. Cheifetz AS, et al. J Clin Gastroenterol. 2011 Feb;45(2):107-12. doi: 10.1097/MCG.0b013e3181e883dd. J Clin Gastroenterol. 2011. PMID: 20679905

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters